Results 321 to 330 of about 749,314 (382)
The value of plasma sCD25 in diagnosis, therapeutic efficacy, and prognosis of acute myeloid leukemia. [PDF]
Wang J+5 more
europepmc +1 more source
Deregulated enhancer‐promoter communication in cancer through altered nuclear architecture
Abstract Enhancers are critical regulators of gene expression. Structural variations in cancer genomes can lead to enhancer hijacking, where oncogenes are activated by mistargeted enhancer activity. Novel enhancer‐promoter interactions may also arise through chromosomal rearrangements that create extrachromosomal DNA elements.
Isabelle Seufert+3 more
wiley +1 more source
PTBP2 promotes cell survival and autophagy in chronic myeloid leukemia by stabilizing BNIP3. [PDF]
Barik B+7 more
europepmc +1 more source
Epigenetic reprogramming in multiple myeloma—Challenges and opportunities
Abstract In cancer, mutational processes act in concert with epigenetic reprogramming to endow malignant cells with hallmark properties that underpin tumorigenesis. Compared with the relatively rigid and slow processes of genetic evolution, the plastic nature of chromatin enables cells to adapt to a changing environment more rapidly.
Subhasree Kumar+2 more
wiley +1 more source
Dynamin2 mutations in newly diagnosed acute myeloid leukemia: clinical characteristics, and prognostic significance. [PDF]
Luo K+8 more
europepmc +1 more source
What's New? About half of penile squamous cell carcinomas are causally associated with inflammatory conditions such as lichen sclerosus (LSc), but few large‐scale studies have assessed the risk of penile cancer in men with LSc. Here, the authors conducted a large nationwide study in Denmark to estimate the risk of penile and non‐penile cancer in men ...
Marianne Gardar Stærk+5 more
wiley +1 more source
Chidamide in Combination With DCAG With or Without Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia. [PDF]
Liu Q+7 more
europepmc +1 more source
Hemophagocytosis in acute myeloid leukemia
Claudia Morales-Olvera+1 more
openaire +3 more sources
Editorial: Molecular MRD testing in patients with acute myeloid leukemia. [PDF]
Blackmon AL, Grunwald MR.
europepmc +1 more source